Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement Jan 17, 2017
Evidence Supporting Interpace Diagnostics' PanDNA® Product Presented at the American College of Gastroenterology Annual Meeting Oct 19, 2016